http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004024063-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E21B21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E21B21-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
filingDate 2001-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_027b5da840a8feb00c5d2343ed7638f4
publicationDate 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004024063-A1
titleOfInvention Fatty acid analogues for the treatment of cancer
abstract The present invention relates to fatty acid analogues of general formula (I): R 1 -[x i -CH 2 ] n —COOR 2 , wherein is: a C 1 -C 24 alkene with one or more double bonds and/or with one or more triple bonds; and/or a C 1 -C 24 alkyne, and/or a C 1 -C 24 alkyl, or an alkyl substituted in one or several positions with one or more compounds selected from the group comprising fluoride, chloride, hydroxy, C 1 -C 4 alkoxy, C 1 -C 4 alkylthio, C 2 -C 5 acyloxy or C 1 -C 4 alkyl, and wherein R 2 represents hydrogen or C 1 -C 4 alkyl, and wherein is an integer from 1 to 12, and wherein i is an odd number and indicates the position relative to COOR 2 , and wherein X i independent of each other are selected from the group comprising O, S, SO, SO 2 , Se and CH 2 , and with the proviso that at least one of the X i is not CH 2 , which can be used for the treatment and/or prevention of primary and secondary metastatic neoplasms.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016201450-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017276951-A1
priorityDate 2000-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5750515-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7026356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6358915-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6046237-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128417453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160416580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142373236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452050526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129647280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454310371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142014047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226563441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226563442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142432920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142290658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142292039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161975891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232

Total number of triples: 79.